Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec 18;17(8):4191-4202.
doi: 10.1039/d5sc06902e. eCollection 2026 Feb 25.

Lanthanide complexes with acetophenone-based push-pull antennas as efficient MRI and two-photon microscopy imaging probes

Affiliations

Lanthanide complexes with acetophenone-based push-pull antennas as efficient MRI and two-photon microscopy imaging probes

Baptiste Chartier et al. Chem Sci. .

Abstract

Lanthanide(iii) (Ln3+) complexes possess unique magnetic and optical properties that make them ideal candidates for the development of multimodal MRI and optical probes. However, the requirements for developing effective MRI and optical probes are difficult to meet within a single ligand. Here, we propose the use of a DOTA-type ligand equipped with a π-extended acetophenone moiety that (i) serves as a coordinating moiety to form stable Ln3+ complexes, (ii) acts as a 2P-excitable push-pull antenna to sensitize Eu3+ luminescence, and (iii) displays a carboxylate handle offering high water solubility and enabling conjugation to biomolecules for targeting purposes. We show that the Ln3+ complexes obtained are kinetically inert and thermodynamically stable. The Gd3+ complex exhibits positive in vivo characteristics with good contrast in all organs and rapid renal clearance, while the corresponding Eu3+ complex has excellent one-photon and two-photon (2P) absorption properties enabling high-quality in vivo 2P microscopy imaging of zebrafish embryos or in vitro imaging of living cells when conjugated to a cell-penetrating peptide.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Fig. 1
Fig. 1. Structure of (A) complexes LnDO3A-APArOR (Ln = Eu or Gd), EuDO3ApicArOR, EuDO3ApicCCArOR, GdDO3A-AP, GdHPDO3A, GdDOTA, GdDO3A and Vasovist, all discussed in the text and (B) conjugate mTAT[EuDO3A-APArOR].
Fig. 2
Fig. 2. Synthetic pathway for (A) EuDO3A-APArOR and GdDO3A-APArOR and (B) mTAT[EuDO3A-APArOR]. In (B), * denotes standard side chain protecting groups.
Fig. 3
Fig. 3. (A) 1P spectroscopy: normalized absorption (black solid lines), excitation (black dashed lines; λem = 615 nm) and emission (red solid lines; λex = 340 nm) spectra of EuDO3A-APArOR in PBS, pH 7.4. (B and C) 2P spectroscopy: (B) quadratic power dependence of the Eu3+ emission (λex = 700 nm) for EuDO3A-APArOR in PBS pH 7.4; data were fitted using I = A × Pn yielding n = 2.01; (C) 2P absorption spectrum (red) measured in PBS superimposed to the wavelength-doubled 1P absorption spectrum (black).
Fig. 4
Fig. 4. (A) 1H NMRD profiles of GdDO3A-APArOR (0.88 mM) at 25 °C (blue), 37 °C (orange), and 50 °C (red). (B) Temperature dependence of the 17O reduced transverse relaxation rates (top) and chemical shifts (bottom) of GdDO3A-APArOR at 9.4 T (9 mM). The dotted lines represent the simultaneous fit of the experimental data points.
Fig. 5
Fig. 5. T 1-Weighted phantom images in mouse serum with GdDO3A-APArOR and GdDOTA (0.3 mM) at room temperature. Images were acquired at 7 T using a spin echo sequence with TE = 10 ms and TR = 400 ms. The intensities are respectively 3.89 × 104, 3.97 × 104 and 1.04 × 104 for GdDO3A-APArOR, GdDOTA, and serum.
Fig. 6
Fig. 6. (A) T1-weighted MR images recorded at 9.4 T of healthy mice pre-injection (left) and 2, 30 and 40 minutes post i.v. injection of GdDO3A-APArOR at 100 µmol kg−1, (B) % of MRI signal enhancement in the spleen, liver, kidneys and muscle, 2, 5, 10, 20, 30, 40 and 50 minutes post i.v. injection of GdDO3A-APArOR at 100 µmol kg−1 (n = 5, ±SD). (C) Gd content in the blood, spleen, liver, kidneys, and pancreas measured by ICP-OES 1 h after injection of GdDO3A-APArOR (blue), GdDOTA (grey), or Vasovist (orange). Data are presented in % of injected dose by organ mass (n = 5, ±SD).
Fig. 7
Fig. 7. Casper zebrafish embryo development expressed as percentages of chorionated, hatched, malformed and dead (A) without injection or after 1 nL of injection of (B) PBS or (C) EuDO3A-APArOR (1 mM) at the single cell stage. The observation was carried out after 24, 48, 72, 96 and 120 hpi. The total number of embryos is 20, 15 and 20 for non-injected, PBS and EuDO3A-APArOR respectively. Data are presented as mean ± SEM. (D) Representative images of the microscopic observation of embryos at 48 and 96 hpi using the microscope Zeiss Stemi 508.
Fig. 8
Fig. 8. (A) 2P microscopy imaging of 72 hours post-fertilization of casper zebrafish embryos intravenously injected with 10 nL of EuDO3A-APArOR (1 mM) and observed 3 h after injection at 720 nm (n = 5 embryos). Scale bar 500 µm. (B) Mean emission spectra in area outlined in blue and green in panel (A.) (C) Linear unmixing of autofluorescence and the Eu3+ signal.
Fig. 9
Fig. 9. 2P microscopy imaging (λex = 720 nm) of living HeLa cells incubated 1 h with mTAT[EuDO3A-APArOR] (5 µM) and dFFLIPTAT (1.5 µM) in RPMI medium. (A) Left panel: differential interference contrast (DIC) image; middle panel: luminescence image recorded with 575–680 nm bp APD detection; right panel: merge. Scale bars correspond to 10 µm. (B) 2P-excited emission spectra (detected with a PMT array and averaged over the whole cell surface) of the cells outlined in red and blue and background (green). (C) Eu3+ luminescence decay in the cell outlined in red.

References

    1. Bünzli J.-C. G. and Eliseeva S. V., in Lanthanide Luminescence, ed P. Hänninen and H. Härmä, Springer Berlin Heidelberg, 2011, pp. 1–45
    1. Bünzli J.-C. G. On the design of highly luminescent lanthanide complexes. Coord. Chem. Rev. 2015;293:19–47. doi: 10.1016/j.ccr.2014.10.013. - DOI
    1. Alexander C. Guo Z. Glover P. B. Faulkner S. Pikramenou Z. Luminescent Lanthanides in Biorelated Applications: From Molecules to Nanoparticles and Diagnostic Probes to Therapeutics. Chem. Rev. 2025;125:2269–2370. doi: 10.1021/acs.chemrev.4c00615. - DOI - PMC - PubMed
    1. Wang M. Kitagawa Y. Hasegawa Y. Current Development of Lanthanide Complexes for Biomedical Applications. Chem.-Asian J. 2024;19:e202400038. doi: 10.1002/asia.202400038. - DOI - PubMed
    1. Mathieu E. Sipos A. Demeyere E. Phipps D. Sakaveli D. Borbas K. E. Lanthanide-based tools for the investigation of cellular environments. Chem. Commun. 2018;54:10021–10035. doi: 10.1039/C8CC05271A. - DOI - PubMed